Wolverine Trading’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $983K | Buy |
+152,000
| New | +$1.04M | ﹤0.01% | 2916 |
|
|
2025
Q2 | – | Sell |
-108,200
| Closed | -$701K | – | 4767 |
|
|
2025
Q1 | $701K | Buy |
+108,200
| New | +$777K | ﹤0.01% | 2586 |
|
|
2024
Q4 | – | Sell |
-122,700
| Closed | -$1.01M | – | 5264 |
|
|
2024
Q3 | $1.01M | Buy |
122,700
+1,900
| +2% | +$12.5K | ﹤0.01% | 2343 |
|
|
2024
Q2 | $842K | Buy |
120,800
+9,600
| +9% | +$72.6K | ﹤0.01% | 2353 |
|
|
2024
Q1 | $1.18M | Sell |
111,200
-23,200
| -17% | -$203K | ﹤0.01% | 2056 |
|
|
2023
Q4 | $1.08M | Sell |
134,400
-90,600
| -40% | -$660K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $1.85M | Buy |
225,000
+102,600
| +84% | +$885K | ﹤0.01% | 1649 |
|
|
2023
Q2 | $958K | Sell |
122,400
-182,000
| -60% | -$1.34M | ﹤0.01% | 2040 |
|
|
2023
Q1 | $2.35M | Sell |
304,400
-259,100
| -46% | -$2.08M | ﹤0.01% | 1274 |
|
|
2022
Q4 | $3.54M | Sell |
563,500
-283,200
| -33% | -$1.98M | 0.01% | 1066 |
|
|
2022
Q3 | $5.88M | Buy |
+846,700
| New | +$5.88M | 0.01% | 767 |
|
|
2022
Q2 | – | Sell |
-312,900
| Closed | -$7.25M | – | 4510 |
|
|
2022
Q1 | $7.25M | Buy |
+312,900
| New | +$7.65M | 0.01% | 859 |
|
|
2021
Q4 | – | Sell |
-432,600
| Closed | -$12.2M | – | 5861 |
|
|
2021
Q3 | $12.2M | Buy |
+432,600
| New | +$12.3M | 0.01% | 713 |
|
|
2021
Q2 | – | Sell |
-341,900
| Closed | -$10.6M | – | 5983 |
|
|
2021
Q1 | $10.6M | Buy |
341,900
+39,700
| +13% | +$1.16M | 0.02% | 668 |
|
|
2020
Q4 | $6.06M | Sell |
302,200
-22,100
| -7% | -$412K | 0.01% | 947 |
|
|
2020
Q3 | $4.83M | Buy |
324,300
+143,900
| +80% | +$2.48M | 0.01% | 875 |
|
|
2020
Q2 | $3.28M | Sell |
180,400
-38,800
| -18% | -$684K | 0.01% | 1067 |
|
|
2020
Q1 | $3.34M | Buy |
+219,200
| New | +$5.29M | 0.01% | 981 |
|
|
2019
Q4 | – | Sell |
-148,400
| Closed | -$3.22M | – | 4646 |
|
|
2019
Q3 | $3.22M | Sell |
148,400
-108,000
| -42% | -$2.47M | 0.01% | 1117 |
|
|
2019
Q2 | $6.47M | Buy |
256,400
+14,800
| +6% | +$351K | 0.02% | 746 |
|
|
2019
Q1 | $5.97M | Buy |
241,600
+10,000
| +4% | +$239K | 0.02% | 779 |
|
|
2018
Q4 | $4.35M | Sell |
231,600
-63,000
| -21% | -$1.5M | 0.01% | 902 |
|
|
2018
Q3 | $7.56M | Sell |
294,600
-74,600
| -20% | -$1.71M | 0.02% | 709 |
|
|
2018
Q2 | $5.88M | Hold |
369,200
| – | – | 0.01% | 769 |
|
|
2018
Q1 | $5.88M | Sell |
369,200
-157,000
| -30% | -$2.92M | 0.01% | 769 |
|
|
2017
Q4 | $10.9M | Buy |
526,200
+277,300
| +111% | +$4.4M | 0.04% | 469 |
|
|
2017
Q3 | $3.57M | Sell |
248,900
-177,700
| -42% | -$2.69M | 0.01% | 971 |
|
|
2017
Q2 | $7.38M | Sell |
426,600
-68,700
| -14% | -$824K | 0.03% | 504 |
|
|
2017
Q1 | $5.49M | Buy |
495,300
+105,600
| +27% | +$1.45M | 0.03% | 606 |
|
|
2016
Q4 | $5.66M | Buy |
389,700
+124,600
| +47% | +$2.29M | 0.03% | 654 |
|
|
2016
Q3 | $6.64M | Buy |
+265,100
| New | +$6.86M | 0.03% | 614 |
|
Other funds holding BHC
PC
GAM
MP
KKRC
Wolverine Trading's BHC Position: Q3 2025 in Review
Wolverine Trading opened a new position in Bausch Health (BHC) in Q3 2025: 18,553 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #5147 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in BHC as recently as Q1 2025.
Wolverine Trading first reported a position in BHC in Q3 2016 and has held it in 27 quarters since. The position peaked at $19.5M in Q3 2021. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.
- Wolverine Trading held 18,553 shares of Bausch Health worth $120K as of Q3 2025.
- Bausch Health was a new Wolverine Trading position in Q3 2025.
- Bausch Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5147 holding.
- Wolverine Trading first reported a position in Bausch Health in Q3 2016 and has held it in 27 quarters since.
- Wolverine Trading's Bausch Health position peaked at $19.5M in Q3 2021.
- 219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.